Have a question about this calculator? Get a detailed answer.
The Columbia Suicide Severity Rating Scale (C-SSRS) is a structured clinical interview developed by Dr. Kelly Posner and colleagues at Columbia University in 2007. It is considered the gold standard for assessing suicidal ideation and behavior in clinical, research, and community settings. Unlike simple screening tools that produce a single score, the C-SSRS provides a hierarchical classification of suicidal ideation severity (five levels from passive wish for death to active ideation with specific plan and intent) and suicidal behavior (four categories from preparatory acts to actual attempts), enabling clinicians to make nuanced risk assessments. The C-SSRS was developed through a collaboration between Columbia University, the University of Pennsylvania, and the University of Pittsburgh, funded by the National Institute of Mental Health. It has been adopted by the United States Food and Drug Administration as the recommended assessment for suicidality in all clinical trials, by the Centers for Disease Control and Prevention for suicide surveillance, by the Department of Defense and Veterans Affairs for military and veteran populations, and by the Joint Commission as a recommended tool for healthcare accreditation. The scale distinguishes between suicidal ideation (thoughts about suicide) and suicidal behavior (actions taken toward suicide), a distinction that is critical for risk assessment and intervention planning. Suicidal ideation is rated on a 5-point ordinal scale: (1) wish to be dead, (2) non-specific active suicidal thoughts, (3) active suicidal ideation with any methods (not plan) without intent to act, (4) active suicidal ideation with some intent to act without specific plan, and (5) active suicidal ideation with specific plan and intent. Suicidal behavior is categorized as: actual attempt, interrupted attempt, aborted attempt, or preparatory acts or behavior. The C-SSRS is available in multiple versions including the full lifetime/recent version, the since-last-visit version for longitudinal monitoring, and the screener version for rapid community and clinical screening. All versions are available at no cost from the Columbia Lighthouse Project, which provides free training and implementation resources.
C-SSRS Suicide Ideation Severity Rating: Level 0: No ideation Level 1: Wish to be dead Level 2: Non-specific active suicidal thoughts Level 3: Active suicidal ideation with any methods, no intent Level 4: Active suicidal ideation with some intent, no specific plan Level 5: Active suicidal ideation with specific plan and intent C-SSRS Suicide Ideation Intensity Rating (for highest severity level endorsed): Frequency (1-5) + Duration (1-5) + Controllability (1-5) + Deterrents (1-5) + Reasons (1-5) = Intensity Score (5-25) Suicidal Behavior Categories: - Actual Attempt (with or without injury) - Interrupted Attempt - Aborted Attempt - Preparatory Acts or Behavior - Non-Suicidal Self-Injurious Behavior (recorded separately) Worked Example: A 32 year old patient during psychiatric evaluation: Suicidal Ideation Assessment: - Wish to be dead: Yes (Level 1 endorsed) - Non-specific active thoughts: Yes (Level 2 endorsed) - Active ideation with methods: Yes, has thought about overdose (Level 3 endorsed) - Active ideation with some intent: Yes, 'I might actually do it' (Level 4 endorsed) - Active ideation with plan and intent: No (Level 5 not endorsed) Highest Severity Level = 4 (Active ideation with some intent, no specific plan) Intensity Rating for Level 4: - Frequency: 2-3 times per week = 3 - Duration: A few hours at a time = 3 - Controllability: Can control with some difficulty = 3 - Deterrents: Deterrents have some effect = 3 - Reasons: Mostly to end pain, some to make others pay attention = 3 Intensity Score = 3 + 3 + 3 + 3 + 3 = 15 Suicidal Behavior: No actual attempts, no interrupted or aborted attempts, no preparatory acts in the assessment period. Risk Classification: HIGH RISK - Active suicidal ideation with intent requires immediate safety intervention, psychiatric evaluation, and consideration of inpatient admission.
- 1Select the Appropriate C-SSRS Version: Choose the version appropriate for the clinical context. The Lifetime/Recent version assesses both lifetime history and a recent period (typically the past month) and is used for initial comprehensive assessments. The Since Last Visit version assesses ideation and behavior since the last clinical contact and is used for longitudinal monitoring in ongoing treatment. The Screener version contains only the ideation questions and is used for rapid screening in emergency departments, primary care, schools, and community settings. The Pediatric version uses simplified language for children aged 6 to 11. All versions are freely available through the Columbia Lighthouse Project.
- 2Assess Suicidal Ideation Using the Hierarchical Questions: Begin with the lowest severity level and progress upward. Ask question 1: 'Have you wished you were dead or wished you could go to sleep and not wake up?' If yes, proceed to question 2: 'Have you actually had any thoughts of killing yourself?' If yes, proceed to question 3: 'Have you been thinking about how you might do this?' If yes, proceed to question 4: 'Have you had these thoughts and had some intention of acting on them?' If yes, proceed to question 5: 'Have you started to work out or worked out the details of how to kill yourself, and do you intend to carry out this plan?' Record the highest level endorsed. If the patient denies ideation at any level, do not proceed to higher levels.
- 3Assess Ideation Intensity for the Highest Endorsed Level: For the highest ideation level endorsed, assess five intensity dimensions. Frequency: how often the thoughts occur (1 = less than once a week to 5 = many times every day). Duration: how long the thoughts last (1 = fleeting seconds to 5 = persistent continuous). Controllability: ability to stop or redirect the thoughts (1 = easily able to control to 5 = unable to control). Deterrents: whether anything prevents acting on the thoughts (1 = deterrents definitely stop from acting to 5 = deterrents do not apply). Reasons for ideation: the motivation behind the thoughts (1 = completely to get attention to 5 = completely to end or stop the pain). Sum these five ratings for the intensity score (range 5-25).
- 4Assess Suicidal Behavior: Independently from ideation, assess whether any suicidal behavior has occurred during the assessment period. An actual attempt is a potentially self-injurious act committed with at least some wish to die. An interrupted attempt is an act that was stopped by an outside circumstance before any self-harm occurred. An aborted attempt is an act that the individual stopped before any self-harm occurred. Preparatory acts include gathering pills, obtaining a weapon, writing a suicide note, or giving away possessions. For each behavior endorsed, record the date, method, medical severity of any injury, and the circumstances. Distinguish suicidal behavior from non-suicidal self-injury, which is self-harm without intent to die.
- 5Assess Medical Lethality of Any Attempts: For any actual suicide attempts, rate the medical severity: 0 = no physical damage, 1 = minor physical damage (superficial scratching), 2 = minor physical damage (bruising, sprains), 3 = moderate physical damage (requiring medical attention), 4 = moderately severe physical damage (requiring hospitalization), 5 = severe physical damage (intensive care required), 6 = death. Also assess the potential lethality: what would have happened without medical intervention. This rating is crucial because a patient who took a lethal overdose but was discovered quickly may have minimal actual injury (low medical severity) but extremely high potential lethality.
- 6Determine the Overall Risk Level: Synthesize the ideation severity, intensity, behavior, and clinical context to determine overall risk level. Low risk: Level 1-2 ideation, low intensity, no behavior, strong protective factors. Moderate risk: Level 3 ideation, moderate intensity, no recent behavior, some protective factors. High risk: Level 4-5 ideation, high intensity, recent behavior (within past 3 months), weak protective factors. Imminent risk: Level 5 ideation with high intensity and low controllability, or recent actual attempt, or current preparatory behavior. The risk level directly informs the disposition decision: outpatient follow-up, urgent psychiatric evaluation, or emergency hospitalization.
- 7Implement Risk-Appropriate Safety Interventions: Based on the risk level, implement appropriate interventions. For low risk: safety planning, means restriction counseling, follow-up appointment within one week. For moderate risk: comprehensive safety plan, means restriction, follow-up within 48 to 72 hours, consider increasing treatment intensity. For high risk: psychiatric evaluation for possible hospitalization, crisis safety plan, means restriction, continuous monitoring until evaluation completed. For imminent risk: do not leave patient alone, initiate emergency psychiatric evaluation, implement one-to-one observation, prepare for possible involuntary hospitalization if patient refuses voluntary admission. Document the C-SSRS results, risk formulation, and intervention plan in the medical record.
This 45 year old patient with chronic pain reports occasional fleeting wishes to be dead, typically during pain flares. She denies any active thoughts of killing herself, has no plan or intent, and identifies her children as strong deterrents. The low ideation severity, low intensity, absence of behavior, and presence of protective factors indicate low risk. Intervention includes a safety plan, pain management optimization, follow-up in one week, and coordination with her pain specialist.
This 28 year old patient endorses the highest level of suicidal ideation with a specific plan (overdose with accumulated medications), chosen date (next weekend), and clear intent. She has been collecting medications as preparatory behavior. The intensity score of 23/25 with poor controllability and absent deterrents indicates imminent risk. The patient should not be left alone. All collected medications should be removed from her possession. Emergency psychiatric evaluation for inpatient admission is initiated immediately. The patient is placed on one-to-one observation.
Despite the current ideation level of only 3 (no current intent), this patient's risk is elevated to HIGH due to the prior near-lethal suicide attempt 6 months ago. Prior attempt history is the single strongest predictor of future suicide. The combination of ongoing active ideation with identified method, moderate intensity, and a recent serious attempt requires intensive outpatient management at minimum, with strong consideration for inpatient stabilization.
FDA Clinical Trial Suicide Safety Monitoring: Since 2012, the FDA has recommended the C-SSRS as the standard measure for assessing treatment-emergent suicidality in clinical trials for all psychiatric medications and many non-psychiatric medications. This recommendation was driven by the black box warning on SSRIs regarding increased suicidality in young adults and the need for a standardized method to detect and report suicidal events across clinical trials. The C-SSRS is now incorporated into the protocols of thousands of active clinical trials worldwide, providing consistent data that enables comparison across studies and early detection of suicide safety signals.
Emergency Department Triage and Disposition: Emergency departments are the frontline for patients in suicidal crisis, with approximately 1.4 million adults visiting US emergency departments for suicidal ideation or self-harm annually. The C-SSRS Screener version has been integrated into emergency department triage protocols at many hospitals, enabling rapid identification of patients who need immediate psychiatric evaluation. The structured severity levels directly inform disposition decisions: patients with Level 1-2 ideation may be safely discharged with safety planning, while patients with Level 4-5 ideation or recent behavior typically require psychiatric evaluation before discharge.
Military and Veteran Suicide Prevention Programs: The Department of Defense and the Department of Veterans Affairs have adopted the C-SSRS as a primary suicide risk assessment tool across all military branches and VA healthcare facilities. Given that veteran suicide rates are approximately 1.5 times higher than the general population, systematic C-SSRS implementation has been a cornerstone of federal suicide prevention strategy. The VA uses the C-SSRS Screener at multiple clinical touchpoints including primary care visits, mental health appointments, and crisis line calls. The Veterans Crisis Line uses a modified C-SSRS protocol to triage the urgency of responses.
School and University Crisis Response: The C-SSRS Screener has been adapted for use by school counselors, residence life staff, and university counseling center clinicians to assess students who disclose suicidal thoughts or who are identified through peer reports or behavioral observation. The structured format helps non-clinician gatekeepers (teachers, coaches, resident advisors) conduct an initial assessment using the screener version while arranging for professional evaluation. Several major university systems have implemented C-SSRS-based protocols that standardize the response to suicidal students across all campus settings.
When assessing patients who are intoxicated with alcohol or drugs, the C-SSRS
When assessing patients who are intoxicated with alcohol or drugs, the C-SSRS should be administered but results interpreted with caution. Intoxication can both elevate suicidal ideation (through disinhibition and emotional amplification) and impair the patient's ability to provide accurate responses. A patient who endorses Level 4-5 ideation while intoxicated must be treated as high risk regardless of whether the ideation may resolve with sobriety. The C-SSRS should be re-administered after the patient is sober to establish a more reliable baseline. Importantly, intoxication itself is a risk factor for suicide: approximately one-third of individuals who die by suicide are intoxicated at the time of death. For patients with chronic suicidal ideation (as commonly seen in borderline personality disorder, chronic pain conditions, and treatment-resistant depression), the C-SSRS Since Last Visit version helps track changes from the patient's baseline level of ideation. A patient with borderline personality disorder who chronically reports Level 2 ideation may not require emergency intervention each time. However, escalation from their baseline (for example, moving from Level 2 to Level 4) represents a clinically significant change that warrants intensified intervention even if Level 4 in another patient might be assessed differently. When administering the C-SSRS across different cultural contexts, be aware that the direct discussion of suicide is taboo or highly stigmatized in many cultures. This may lead to underreporting even with direct questions. In cultures where suicide discussion is avoided, building rapport, normalizing the screening process, and using culturally appropriate language are essential. Some patients may express suicidal ideation indirectly through statements about wanting to join deceased relatives, feeling like a burden, or expressing hopelessness about the future.
| Ideation Level | Description | Risk Classification | Recommended Action | Monitoring Frequency |
|---|---|---|---|---|
| 0 | No ideation | Baseline | Document, routine follow-up | Next scheduled visit |
| 1 | Wish to be dead | Low | Safety planning, means restriction counseling | 1-2 weeks |
| 2 | Non-specific active thoughts | Low-Moderate | Safety plan, increase treatment, follow-up | 1 week |
| 3 | Active ideation with methods, no intent | Moderate | Enhanced safety plan, urgent follow-up | 48-72 hours |
| 4 | Active ideation with some intent | High | Psychiatric evaluation, consider hospitalization | 24-48 hours or inpatient |
| 5 | Active ideation with plan and intent | Imminent | Emergency psychiatric evaluation, do not leave alone | Continuous until evaluated |
| Any + recent behavior | Ideation plus behavioral history | Elevated above ideation-only | Factor behavior history into risk formulation | Per behavior severity |
Do I need training to administer the C-SSRS?
The Columbia Lighthouse Project provides free online training for all versions of the C-SSRS. The screener version can be administered by non-clinicians (teachers, police officers, hotline workers) after completing the brief online training module. The full clinical version requires more clinical judgment and is typically administered by mental health professionals, physicians, nurses, or trained clinical research staff. All training is available at no cost through cssrs.columbia.edu. The training includes practice scenarios and guidance on how to respond to different levels of risk.
What is the difference between an interrupted attempt and an aborted attempt?
The distinction lies in whether the interruption comes from outside or inside the individual. An interrupted attempt occurs when an outside person or circumstance prevents completion of the act after the individual has already initiated it (for example, someone walks in while the person is tying a noose, or a gun jams). An aborted attempt occurs when the individual themselves stops the act before any harm occurs (for example, putting down the pills after picking them up, stepping back from the ledge). This distinction is clinically meaningful because interrupted attempts suggest higher intent (the person did not stop themselves) and may indicate greater risk.
How does the C-SSRS handle non-suicidal self-injury?
The C-SSRS includes a category for non-suicidal self-injurious behavior (NSSI), defined as self-harm without any intent to die. Common forms include cutting, burning, hitting, and scratching. NSSI is recorded separately from suicidal behavior because the clinical significance and treatment approach differ. However, the C-SSRS recognizes that NSSI is a risk factor for future suicidal behavior: individuals who engage in NSSI are approximately 3 to 4 times more likely to attempt suicide than those who do not. When NSSI is endorsed, clinicians should assess whether there is a clear absence of suicidal intent, as patients sometimes underreport suicidal intent in self-harm episodes.
Can the C-SSRS be used with children?
Yes. A pediatric version of the C-SSRS has been developed for children aged 6 to 11 that uses simplified language appropriate for younger developmental levels. For example, rather than asking about 'suicidal ideation,' the pediatric version asks 'Have you wished you were dead?' and 'Have you had any thoughts about killing yourself?' using concrete, developmentally appropriate language. The C-SSRS has been validated in pediatric populations as young as 6 years old. Given that suicide is the second leading cause of death among children aged 10 to 14, age-appropriate assessment tools are critically important.
What should I do if a patient denies ideation but I suspect they are not being truthful?
Clinical suspicion of concealed suicidal ideation should be taken seriously. Risk factors that may be present despite denied ideation include: recent major loss, known psychiatric diagnosis, prior attempt history, substance intoxication, agitation or emotional dysregulation, giving away possessions, making final arrangements, and statements about being a burden. When clinical suspicion is high despite denied ideation, document the discrepancy between reported ideation and clinical observations, maintain appropriate safety precautions, involve collateral informants (family, friends) if possible, and schedule close follow-up. The C-SSRS should be repeated as clinical circumstances change, as denial may reflect ambivalence rather than true absence of ideation.
How does the C-SSRS compare to other suicide assessment tools?
The C-SSRS is distinguished from other tools by several features. Unlike the PHQ-9 (which has a single suicide screening item), the C-SSRS provides a comprehensive, hierarchical assessment of both ideation and behavior. Unlike the Beck Scale for Suicide Ideation (which produces a continuous severity score), the C-SSRS provides categorical classifications that directly map to clinical decision-making. Unlike the SAD PERSONS scale (which relies on demographic risk factors), the C-SSRS directly assesses the content of suicidal thoughts and actions. The C-SSRS has been endorsed by more regulatory and governmental bodies than any other suicide assessment tool, establishing it as the de facto international standard.
Pro Tip
When administering the C-SSRS, do not shy away from asking the questions directly and explicitly. Research consistently shows that asking about suicide does not increase suicidal ideation or behavior. In fact, patients often report relief when asked directly about suicidal thoughts. The most effective approach is calm, direct, and compassionate: 'I am going to ask you some questions about thoughts of suicide. These are questions I ask all my patients because it helps me provide better care. There are no wrong answers.' Avoid euphemisms like 'hurting yourself' when you mean 'killing yourself' because vague language can lead to inaccurate responses.
Did you know?
The C-SSRS gained worldwide attention when the FDA mandated its use in all psychiatric drug clinical trials following the controversy over SSRI-associated suicidality in adolescents. Before the C-SSRS, different pharmaceutical companies used different measures to assess suicidality, making cross-study comparisons nearly impossible. The Columbia team was given the challenge of creating a single tool that would work across all populations, languages, and clinical settings. The result has been translated into over 140 languages and is used in more than 100 countries, making it the most widely implemented suicide assessment tool in history.
References
- ›The Columbia Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings - Posner et al., American Journal of Psychiatry, 2011
- ›Columbia Lighthouse Project - Free C-SSRS Training and Resources
- ›FDA Guidance: Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials, 2012
Get Weekly Math Tips
Join 12,000+ subscribers who get calculator tips every week.